India Today has put the scientific basis of Deepinder Goyal’s Temple wearable under scrutiny in its November 6 coverage. The question matters for Indian innovation: a product’s ambition and its supporting evidence need to be assessed separately. [18]
What the coverage establishes
One India Today headline identifies Temple as an Rs 85,000 wearable and frames its science as the larger test. A later headline presents the discussion as a disagreement between startup founders and doctors. [18][13]
These are two leads from the same publication, not independent confirmation of the underlying arguments. They supply no study results, specific medical claims or named expert assessments. They therefore cannot establish that the device is either effective or ineffective. [18][13]
Evidence before endorsement
Sanatan Daily’s assessment is that the useful issue is not a contest between professions. It is whether a product’s stated purpose, testing methods and results can withstand appropriate scrutiny.
Supporting Indian entrepreneurship does not require premature endorsement. Equally, raising questions about evidence is not grounds for dismissing an invention before its claims have been examined.
The constructive next step is transparent information about what the wearable claims to measure and how those measurements are validated. That would give consumers and researchers a firmer basis for judgement than competing assertions.

